Aquapass is the developer and manufacturer of innovative solutions for the treatment of fluid overload and congestion in acutely decompensated heart failure patients, end-stage kidney disease (ESKD) chronic kidney disease, and lymphedema patients
Aquapass is the developer and manufacturer of innovative solutions for the treatment of fluid overload and congestion in acutely decompensated heart failure patients, end-stage kidney disease (ESKD) chronic kidney disease, and lymphedema patients. The treatment is non-invasive and bypasses the renal system.